慢性淋巴细胞白血病免疫检查点治疗的当前方法
Saeid Taghiloo1, Hossein Asgarian-Omran2,3
1Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Current treatment options in oncology
|August 10, 2023
概括
通过准免疫检查点,正在开发针对慢性淋巴细胞白血病 (CLL) 的新型免疫疗法. 目前正在进行研究,以提高CLL患者免疫检查点阻塞 (ICB) 疗法的有效性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 慢性淋巴细胞白血病 (CLL) 涉及白血病和免疫细胞之间的复杂相互作用,推动瘤进展和免疫逃避.
- 免疫检查点分子被瘤细胞调高,作为一种逃生机制.
- 通过免疫检查点阻塞 (ICB) 准免疫检查点是针对各种癌症的临床有效的免疫疗法策略.
研究的目的:
- 探索慢性淋巴细胞白血病 (CLL) 的新型免疫治疗方法.
- 研究免疫检查点分子在CLL进展和免疫逃避中的作用.
- 确定提高免疫检查点封锁 (ICB) 在CLL中的有效性的策略.
主要方法:
- 审查目前对CLL中白血病免疫细胞相互作用的理解.
- 分析免疫检查点路径作为治疗点.
- 评估ICB在血液性恶性瘤中的临床有效性,重点关注CLL.
主要成果:
- 对白血病免疫细胞相互作用的理解导致了对CLL的新型免疫疗法开发.
- 免疫检查点阻塞 (ICB) 与其他血液恶性瘤相比,在CLL患者中表现出有限的成功.
- 目前正在进行的研究旨在优化ICB策略,以改善CLL的抗瘤免疫反应.
结论:
- 准免疫检查点是CLL免疫疗法的有希望的途径.
- 提高ICB的疗效对于改善CLL患者的临床结果至关重要.
- 需要进一步的研究来克服与CLL的ICB治疗相关的挑战.
相关概念视频
01:27Tumor Immunotherapy
557
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
557
01:27Cytotoxic T Cells-mediated Immune Response
971
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
971
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K